AstraZeneca (Brazil)
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 · Mark G. Kris, Ronald B. Natale, et al. · JAMA
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 · Carole L. Marcus, Lee J. Brooks, et al. · PEDIATRICS
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
2011 · Masahiro Fukuoka, Yi‐Long Wu, et al. · Journal of Clinical Oncology